Reaction profile
The FDA adverse-event record for head tilt - ear disorder
1,848 FDA reports name head tilt - ear disorder, a high-volume reaction in the CVM extract (VeDDRA 374). Plate stamps and neighbourhood peers follow.
- #248 of 2,481
- by report volume (all reactions)
- 1,848
- reports citing this reaction
- 10.8%
- death-coded share
- Dog
- most-affected species
Release-over-release change
What changed in the latest FDA data snapshot
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Head tilt - ear disorder has 1,848 reports now versus 1,821 in that prior snapshot: 27 more (1.5%).
- Report change
- +27
- Death-coded reports
- +2
- Death-coded share
- −0.0 pts
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Head tilt - ear disorder changesFDA AER · VeDDRA plate
Code 374 VOL-MID
VOL-MID · DEATH-ELEV · TOP-DECILE · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL
- VOL-MID 1,848 reports
- DEATH-ELEV 10.8%
- TOP-DECILE #248/2481
- PHOTO-FINISH Decreased activity
- SPECIES-DOG Dog · 1,416
- DRUG-LEAD Florfenicol + Mom… · 369
- DESK-WIDE 20 breeds
- BOOK-FULL 8/8 fields
Nearest volume peer: Decreased activity (±7 reports)
Upper-third report volume drives the scale stamps on this plate; death-coded share and co-report peers follow. Not a clinical diagnosis.
High-volume neighbourhood around Head tilt - ear disorder
Upper-third volume poles plus nearest peers, not a full reaction corpus board reprint.
What the FDA AER plate says about Head tilt - ear disorder
Signature read: 1,848 reports place Head tilt - ear disorder in the upper third of FDA AER volume (#248 of 2,481). Report volume is upper-third scale: 1,848 named reports in the openFDA extract. 199 of 1,848 reports were death-coded (10.8% of named reports, not a population mortality rate). Nearest volume peer: Decreased activity (±7 reports). Lead species Dog (1,416). Lead co-reported drug Florfenicol + Mometasone Furoate + Terbinafine Hydrochloride (369).
Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Florfenicol + Mometasone Furoate + Terbinafine Hydrochloride appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.
Species Most Affected
Breeds Most Affected
Associated Drugs
Nationwide reactions with similar profiles
Two openFDA-derived peer sets for Head tilt - ear disorder, both floored at ≥50 reports so the neighborhoods stay in the advertised mass (the volume chart above is the unfloored photo-finish strip).
Similar report volume
Nearest other reactions by FDA report count (1,848 here).
Similar death-coded share
Nearest other reactions by death-coded share (10.8% here), distinct from the volume row.
What to do with this reaction
- Compare Head tilt - ear disorder's report profile against similar reactions nationwide. See similar reactions
- Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
- Browse the full reaction directory to compare report counts across reaction types. All reactions
A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →